Assertio Holdings Inc (ASRT)
0.9998
+0.09
(+9.39%)
USD |
NASDAQ |
May 02, 16:00
0.9998
0.00 (0.00%)
After-Hours: 18:12
Assertio Holdings Free Cash Flow (Quarterly): 5.607M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.607M |
| September 30, 2023 | 2.579M |
| June 30, 2023 | 18.07M |
| March 31, 2023 | 22.72M |
| December 31, 2022 | 26.70M |
| September 30, 2022 | 10.04M |
| June 30, 2022 | 14.43M |
| March 31, 2022 | 27.43M |
| December 31, 2021 | 4.131M |
| September 30, 2021 | 4.654M |
| June 30, 2021 | 0.964M |
| March 31, 2021 | -4.226M |
| December 31, 2020 | -5.982M |
| September 30, 2020 | -14.43M |
| June 30, 2020 | -20.10M |
| March 31, 2020 | -25.07M |
| December 31, 2019 | 7.90M |
| September 30, 2019 | 33.01M |
| June 30, 2019 | 20.91M |
| March 31, 2019 | 27.18M |
| December 31, 2018 | 14.24M |
| September 30, 2018 | 67.56M |
| June 30, 2018 | 12.17M |
| March 31, 2018 | -26.98M |
| December 31, 2017 | 27.16M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.265M |
| June 30, 2017 | 22.07M |
| March 31, 2017 | 15.54M |
| December 31, 2016 | 40.96M |
| September 30, 2016 | 17.04M |
| June 30, 2016 | 26.53M |
| March 31, 2016 | -16.12M |
| December 31, 2015 | 40.98M |
| September 30, 2015 | 48.73M |
| June 30, 2015 | 38.78M |
| March 31, 2015 | -2.835M |
| December 31, 2014 | 3.42M |
| September 30, 2014 | -0.762M |
| June 30, 2014 | 6.805M |
| March 31, 2014 | -65.98M |
| December 31, 2013 | -1.11M |
| September 30, 2013 | 13.90M |
| June 30, 2013 | 0.479M |
| March 31, 2013 | -5.479M |
| December 31, 2012 | -10.45M |
| September 30, 2012 | 24.39M |
| June 30, 2012 | -40.15M |
| March 31, 2012 | -11.65M |
| December 31, 2011 | -14.76M |
| September 30, 2011 | -9.924M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-25.07M
Minimum
Mar 2020
33.01M
Maximum
Sep 2019
6.807M
Average
5.607M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Ocular Therapeutix Inc | -22.91M |
| Cormedix Inc | -11.04M |
| Verastem Inc | -29.68M |
| Puma Biotechnology Inc | 10.41M |
| CytomX Therapeutics Inc | -22.23M |